Regen BioPharma, Inc.
RGBP
$0.055
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 700.00 | 61.80K | 78.10K | 124.50K | 121.00K |
| Total Receivables | 94.90K | 67.10K | 39.70K | 12.30K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 64.30K | 23.40K | 5.20K | 5.00K | 10.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 0.00 | -- | -- |
| Total Current Assets | 159.90K | 152.40K | 123.00K | 141.80K | 131.00K |
|
|
|||||
| Total Current Assets | 159.90K | 152.40K | 123.00K | 141.80K | 131.00K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 177.60K | 170.20K | 140.80K | 159.50K | 353.60K |
|
|
|||||
| Total Accounts Payable | 29.70K | 29.40K | 29.80K | 44.20K | 29.70K |
| Total Accrued Expenses | 1.66M | 1.66M | 1.64M | 1.66M | 1.64M |
| Short-term Debt | 294.80K | 219.20K | 50.20K | 50.20K | 96.70K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 499.90K | 499.90K | 499.90K | 509.90K | 509.90K |
| Total Finance Division Other Current Liabilities | 2.88M | 2.92M | 2.95M | 2.98M | 3.03M |
| Total Other Current Liabilities | 2.88M | 2.92M | 2.95M | 2.98M | 3.03M |
| Total Current Liabilities | 5.37M | 5.33M | 5.17M | 5.25M | 5.31M |
|
|
|||||
| Total Current Liabilities | 5.37M | 5.33M | 5.17M | 5.25M | 5.31M |
| Long-Term Debt | -- | -- | 143.70K | 154.00K | 149.60K |
| Short-term Debt | 294.80K | 219.20K | 50.20K | 50.20K | 96.70K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00 | -- | 0.00 |
| Total Liabilities | 5.37M | 5.33M | 5.32M | 5.40M | 5.46M |
|
|
|||||
| Common Stock & APIC | 15.42M | 15.19M | 15.05M | 14.86M | 14.64M |
| Retained Earnings | -20.62M | -20.35M | -20.22M | -20.10M | -19.75M |
| Treasury Stock & Other | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Common Equity | -5.20M | -5.16M | -5.18M | -5.24M | -5.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 1.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.00K | 0.00 | 0.00 | 0.00 | 0.00 |
|
|
|||||
| Total Common Equity | -5.20M | -5.16M | -5.18M | -5.24M | -5.10M |
| Total Preferred Equity | 1.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.19M | -5.16M | -5.18M | -5.24M | -5.10M |
|
|
|||||